| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advances in the preparation and synthesis of heparin and related products
|
Baytas, Sultan N.
|
|
|
25 |
12 |
p. 2095-2109
|
artikel
|
| 2 |
Analysis of clinical trials of new drugs in China as of 2019
|
Lin, Longfei
|
|
|
25 |
12 |
p. 2080-2088
|
artikel
|
| 3 |
A new perspective in sepsis treatment: could RGD-dependent integrins be novel targets?
|
Nader, Danielle
|
|
|
25 |
12 |
p. 2317-2325
|
artikel
|
| 4 |
Can easy chemistry produce complex, diverse, and novel molecules?
|
Tomberg, Anna
|
|
|
25 |
12 |
p. 2174-2181
|
artikel
|
| 5 |
CDK12: a potential therapeutic target in cancer
|
Emadi, Fatemeh
|
|
|
25 |
12 |
p. 2257-2267
|
artikel
|
| 6 |
Contents page 2
|
|
|
|
25 |
12 |
p. ii
|
artikel
|
| 7 |
Contents page 1
|
|
|
|
25 |
12 |
p. i
|
artikel
|
| 8 |
Crowdsourcing and open innovation in drug discovery: recent contributions and future directions
|
Thompson, David C.
|
|
|
25 |
12 |
p. 2284-2293
|
artikel
|
| 9 |
Danger in the Valley of Death: how the transition from preclinical research to clinical trials can impact valuations
|
Truebel, Hubert
|
|
|
25 |
12 |
p. 2089-2094
|
artikel
|
| 10 |
Drug discovery and development in idiopathic pulmonary fibrosis: challenges and opportunities
|
Cruwys, Simon
|
|
|
25 |
12 |
p. 2277-2283
|
artikel
|
| 11 |
Efflux pumps as interventions to control infection caused by drug-resistance bacteria
|
Farhat, Nabeela
|
|
|
25 |
12 |
p. 2307-2316
|
artikel
|
| 12 |
Exosomes as therapeutic solutions for pancreatic cancer
|
Farran, Batoul
|
|
|
25 |
12 |
p. 2245-2256
|
artikel
|
| 13 |
Medicinal chemistry perspective of TRPM2 channel inhibitors: where we are and where we might be heading?
|
Zhang, Han
|
|
|
25 |
12 |
p. 2326-2334
|
artikel
|
| 14 |
MELK/MPK38 in cancer: from mechanistic aspects to therapeutic strategies
|
Thangaraj, Karthik
|
|
|
25 |
12 |
p. 2161-2173
|
artikel
|
| 15 |
New approaches for antituberculosis leads from Actinobacteria
|
Hussain, Aehtesham
|
|
|
25 |
12 |
p. 2335-2342
|
artikel
|
| 16 |
Psoriasis: pathological mechanisms, current pharmacological therapies, and emerging drug delivery systems
|
Rapalli, Vamshi Krishna
|
|
|
25 |
12 |
p. 2212-2226
|
artikel
|
| 17 |
Recent advances in targeted nanomedicine as promising antitumor therapeutics
|
Hejmady, Siddhanth
|
|
|
25 |
12 |
p. 2227-2244
|
artikel
|
| 18 |
Recent advances in ultrasound-triggered drug delivery through lipid-based nanomaterials
|
Ahmadi, Amirhossein
|
|
|
25 |
12 |
p. 2182-2200
|
artikel
|
| 19 |
Recent progress on cheminformatics approaches to epigenetic drug discovery
|
Sessions, Zoe
|
|
|
25 |
12 |
p. 2268-2276
|
artikel
|
| 20 |
Smart treatment strategies for alleviating tauopathy and neuroinflammation to improve clinical outcome in Alzheimer's disease
|
Tatiparti, Katyayani
|
|
|
25 |
12 |
p. 2110-2129
|
artikel
|
| 21 |
Taming the cytokine storm: repurposing montelukast for the attenuation and prophylaxis of severe COVID-19 symptoms
|
Sanghai, Nitesh
|
|
|
25 |
12 |
p. 2076-2079
|
artikel
|
| 22 |
Targeting kinases with thymoquinone: a molecular approach to cancer therapeutics
|
Afrose, Syeda Samira
|
|
|
25 |
12 |
p. 2294-2306
|
artikel
|
| 23 |
The political economics of cancer drug discovery and pricing
|
Taylor, David G.
|
|
|
25 |
12 |
p. 2149-2160
|
artikel
|
| 24 |
Therapeutic aspects of the Axl/Gas6 molecular system
|
Di Stasi, Rossella
|
|
|
25 |
12 |
p. 2130-2148
|
artikel
|
| 25 |
Virus-, host-, immune-based targets for COVID-19 therapy
|
Liu, Wei
|
|
|
25 |
12 |
p. 2071-2073
|
artikel
|
| 26 |
Why next generation radiopharmaceuticals will play a key role in the quest for precision medicine
|
Edwards, Paul
|
|
|
25 |
12 |
p. 2074-2075
|
artikel
|
| 27 |
Zebrafish as a model for inflammation and drug discovery
|
Zanandrea, Rodrigo
|
|
|
25 |
12 |
p. 2201-2211
|
artikel
|
Tijdschrift beschrijving